These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1093 related items for PubMed ID: 28093710

  • 1. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO.
    Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
    [Abstract] [Full Text] [Related]

  • 2. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE, Bourne JN, Evangelou AV, Khandker L, Macklin WB, Wood TL.
    J Neurosci; 2017 Aug 02; 37(31):7534-7546. PubMed ID: 28694334
    [Abstract] [Full Text] [Related]

  • 3. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS, Blakemore WF.
    Adv Exp Med Biol; 1999 Aug 02; 468():183-97. PubMed ID: 10635029
    [Abstract] [Full Text] [Related]

  • 4. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE, Kuhlmann T, Antel JP.
    Biochim Biophys Acta; 2011 Feb 02; 1812(2):184-93. PubMed ID: 20887785
    [Abstract] [Full Text] [Related]

  • 5. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA, Akirav EM.
    J Neurosci Res; 2015 May 02; 93(5):687-96. PubMed ID: 25287108
    [Abstract] [Full Text] [Related]

  • 6. Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
    Rone MB, Cui QL, Fang J, Wang LC, Zhang J, Khan D, Bedard M, Almazan G, Ludwin SK, Jones R, Kennedy TE, Antel JP.
    J Neurosci; 2016 Apr 27; 36(17):4698-707. PubMed ID: 27122029
    [Abstract] [Full Text] [Related]

  • 7. Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
    Zhao C, Ma D, Zawadzka M, Fancy SP, Elis-Williams L, Bouvier G, Stockley JH, de Castro GM, Wang B, Jacobs S, Casaccia P, Franklin RJ.
    J Neurosci; 2015 Aug 19; 35(33):11482-99. PubMed ID: 26290228
    [Abstract] [Full Text] [Related]

  • 8. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
    Cui QL, Kuhlmann T, Miron VE, Leong SY, Fang J, Gris P, Kennedy TE, Almazan G, Antel J.
    Am J Pathol; 2013 Aug 19; 183(2):516-25. PubMed ID: 23746653
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
    Gorter RP, Baron W.
    Neurosci Lett; 2020 Jun 11; 729():134980. PubMed ID: 32315713
    [Abstract] [Full Text] [Related]

  • 10. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
    Unal DB, Caliari SR, Lampe KJ.
    Brain Res Bull; 2019 Oct 11; 152():159-174. PubMed ID: 31306690
    [Abstract] [Full Text] [Related]

  • 11. Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
    Palazuelos J, Klingener M, Raines EW, Crawford HC, Aguirre A.
    J Neurosci; 2015 Sep 02; 35(35):12241-7. PubMed ID: 26338334
    [Abstract] [Full Text] [Related]

  • 12. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
    Wegener A, Deboux C, Bachelin C, Frah M, Kerninon C, Seilhean D, Weider M, Wegner M, Nait-Oumesmar B.
    Brain; 2015 Jan 02; 138(Pt 1):120-35. PubMed ID: 25564492
    [Abstract] [Full Text] [Related]

  • 13. Remyelinating strategies in multiple sclerosis.
    Luessi F, Kuhlmann T, Zipp F.
    Expert Rev Neurother; 2014 Nov 02; 14(11):1315-34. PubMed ID: 25331418
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of remyelination: recent insight from experimental models.
    Tanaka T, Yoshida S.
    Biomol Concepts; 2014 Aug 02; 5(4):289-98. PubMed ID: 25372760
    [Abstract] [Full Text] [Related]

  • 15. The complex world of oligodendroglial differentiation inhibitors.
    Kremer D, Aktas O, Hartung HP, Küry P.
    Ann Neurol; 2011 Apr 02; 69(4):602-18. PubMed ID: 21520230
    [Abstract] [Full Text] [Related]

  • 16. Activation of oligodendroglial Stat3 is required for efficient remyelination.
    Steelman AJ, Zhou Y, Koito H, Kim S, Payne HR, Lu QR, Li J.
    Neurobiol Dis; 2016 Jul 02; 91():336-46. PubMed ID: 27060559
    [Abstract] [Full Text] [Related]

  • 17. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
    Mei F, Mayoral SR, Nobuta H, Wang F, Desponts C, Lorrain DS, Xiao L, Green AJ, Rowitch D, Whistler J, Chan JR.
    J Neurosci; 2016 Jul 27; 36(30):7925-35. PubMed ID: 27466337
    [Abstract] [Full Text] [Related]

  • 18. miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS.
    Wang H, Moyano AL, Ma Z, Deng Y, Lin Y, Zhao C, Zhang L, Jiang M, He X, Ma Z, Lu F, Xin M, Zhou W, Yoon SO, Bongarzone ER, Lu QR.
    Dev Cell; 2017 Mar 27; 40(6):566-582.e5. PubMed ID: 28350989
    [Abstract] [Full Text] [Related]

  • 19. Targeting the Subventricular Zone to Promote Myelin Repair in the Aging Brain.
    Butt AM, Rivera AD, Fulton D, Azim K.
    Cells; 2022 May 31; 11(11):. PubMed ID: 35681504
    [Abstract] [Full Text] [Related]

  • 20. Dendrosomal nanocurcumin promotes remyelination through induction of oligodendrogenesis in experimental demyelination animal model.
    Motavaf M, Sadeghizadeh M, Babashah S, Zare L, Javan M.
    J Tissue Eng Regen Med; 2020 Oct 31; 14(10):1449-1464. PubMed ID: 32750189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.